Clover Health Investments, Corp. CLOV
4.29 USD -0.02 (-0.46%)
At closeNov 3, 2026, 7:19 PM EST
4.30 +0.01 +0.23%
After hours · Nov 3, 7:19 PM ET
4.19 Day range 4.37
1.58 52-week range 5.59
- YTD
- +82.55%
- 1 year
- +16.58%
News
benzinga.com This Kazia Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday Analysts initiated coverage with Buy/Overweight ratings on KZIA ($27), PSQL ($12), NSRX ($7) and LGCY ($16).
benzinga.com This Rubrik Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday Analysts initiated bullish coverage on Rubrik, Kardigan, MSG Rangers and Ormat Technologies, with price targets of $155, $50, $257 and $123.
benzinga.com This Spero Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday Analysts initiated coverage: Hold ALHC; Overweight/$6 SPRO; Buy/$3 LABT; Buy/$6 CLOV.
benzinga.com Needham Initiates Coverage On Clover Health Investments with Buy Rating, Announces Price Target of $6 Needham analyst Matthew Shea initiates coverage on Clover Health Investments (NASDAQ:CLOV) with a Buy rating and announces Price Target of $6.
globenewswire.com Clover Health to Participate in Upcoming UBS Global Healthcare Conference WILMINGTON, Del., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Interim Chief Financial…
defenseworld.net Clover Health Investments (NASDAQ:CLOV) Insider Karen Soares Sells 14,673 Shares of Company Stock Clover Health Investments, Corp. (NASDAQ: CLOV - Get Free Report) insider Karen Soares sold 14,673 shares of Clover Health Investments stock in a transaction on Thursday, October 15th. The stock was…
defenseworld.net Clover Health Investments (NASDAQ:CLOV) CEO Andrew Toy Sells 62,176 Shares of Stock Clover Health Investments, Corp. (NASDAQ: CLOV - Get Free Report) CEO Andrew Toy sold 62,176 shares of the firm's stock in a transaction dated Thursday, October 15th. The shares were sold at an…
defenseworld.net Clover Health Investments (NASDAQ:CLOV) CEO Conrad Wai Sells 23,627 Shares of Stock Clover Health Investments, Corp. (NASDAQ: CLOV - Get Free Report) CEO Conrad Wai sold 23,627 shares of the business's stock in a transaction that occurred on Thursday, October 15th. The shares were…
globenewswire.com Clover Health Earns Top Honors in U.S. News & World Report's 2027 Medicare Advantage Ratings Across Three States WILMINGTON, Del., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health” or “Clover”), a physician enablement technology company committed to bringing…
benzinga.com QUICK SPARK: UnitedHealth Calls 2026 the Bottom for Medicaid Margins UnitedHealth expects Medicaid margins to bottom in 2026 and improve through 2028, UnitedHealthcare CEO Tim Noel says on earnings call.
benzinga.com Clover Health Stock Pops: What's Happening? Clover Health Investments shares are jumping after CMS awarded the company's Medicare Advantage plans high 2027 Star ratings.
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers Humana (NYSE:HUM) stock moved upwards by 16.2% to $450.0 during Friday's pre-market session. The market value of their outstanding shares is at $46.4 billion. XORTX Therapeutics (NASDAQ:XRTX)…
globenewswire.com Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027 WILMINGTON, Del., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that the Centers for Medicare &…
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers SCWorx Corp. - Common Stock (NASDAQ:WORX) shares moved upwards by 48.8% to $6.25 during Thursday's after-market session. XORTX Therapeutics (NASDAQ:XRTX) stock increased by 22.7% to $2.27.…
247wallst.com At 67, He’ll Keep His Clover Medicare Advantage Plan for 2027. The Premium Will Stay $0. The Most He Can Be Billed Will Jump $1,144 A $0 monthly premium sounds like free coverage until you read the pages most people skip. One number buried in the Annual Notice of Change quietly decides how much a serious diagnosis will actually…
globenewswire.com Clover Health to Report Third Quarter 2026 Financial Results on November 4, 2026 WILMINGTON, Del., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial…
globenewswire.com Clover Health's 2027 Medicare Advantage Plans Emphasize PPO Choice, Preventive Care and Member Value WILMINGTON, Del., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed…
globenewswire.com UPDATE – Clover Health Welcomes Former U.S. Senator Robert Torricelli and Dr. Brian J. Miller M.D. WILMINGTON, Del., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced the appointments of former U.S.…
globenewswire.com Clover Health Welcomes Former U.S. Senator Robert Torricelli and MedPAC Commissioner Dr. Brian J. Miller M.D. WILMINGTON, Del., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced the appointments of former U.S.…
benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
marketbeat.com Clover Health Sees PPO Edge, Cohort Gains as Medicare Advantage Pricing Tightens Clover Health Investments NASDAQ: CLOV is positioning its Medicare Advantage business to benefit from industry pricing discipline, member retention and the maturation of member cohorts, Interim Chief…
defenseworld.net Tidal Investments LLC Takes $2.16 Million Position in Clover Health Investments, Corp. $CLOV Tidal Investments LLC purchased a new stake in shares of Clover Health Investments, Corp. (NASDAQ: CLOV) during the undefined quarter, according to the company in its most recent filing with the…
defenseworld.net Clover Health Investments (NASDAQ:CLOV) Stock Price Down 6.5% Following Insider Selling Clover Health Investments, Corp. (NASDAQ: CLOV - Get Free Report)'s stock price fell 6.5% during trading on Tuesday after an insider sold shares in the company. The company traded as low as $4.70 and…
benzinga.com Wealthfront, Orchestra Biomed, AeroVironment And Other Big Stocks Moving Higher On Thursday U.S. stocks fell, but Wealthfront surged 6.6% after beating Q2 earnings and revenue estimates; Orchestra Biomed, Clover Health and AeroVironment also rose.
globenewswire.com Clover Health to Participate in Upcoming Investor Conferences WILMINGTON, Del., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced its participation in the following…
seekingalpha.com Clover Health Is A 'Buy' Because Of Its AI Clover Health Investments, Corp. leverages its AI-powered Clover Assistant to drive lower claims costs and improve member profitability. Baseline and bullish DCF valuations yield fair values of $5.02…
seekingalpha.com Clover Health Investments: Real Turnaround, But Already Priced In Clover Health Investments (CLOV) is rated Hold, with operational execution but a cautious outlook due to valuation and litigation risks. CLOV's Medicare Advantage membership grew 48% YoY, revenue and…
seekingalpha.com Clover Health Is Proving Its Profit Model Clover Health (CLOV) has delivered strong growth, profitability, and improved guidance, supporting my continued Strong Buy rating. CLOV's Medicare Advantage membership grew 48% YoY, with revenue up…
marketbeat.com Clover Health Eyes 2026 GAAP Profit as AI Platform Fuels Medicare Advantage Growth Clover Health Investments NASDAQ: CLOV is positioning its Medicare Advantage model around earlier identification and treatment of chronic conditions, Interim Chief Financial Officer Clay Thornton…
benzinga.com UBS Maintains Neutral on Clover Health Investments, Raises Price Target to $5 UBS analyst Jonathan Yong maintains Clover Health Investments (NASDAQ:CLOV) with a Neutral and raises the price target from $4.75 to $5.
benzinga.com Motorola Solutions Posts Upbeat Q2 Earnings, Joins Insmed, Diodes, Parker-Hannifin And Other Big Stocks Moving Higher On Thursday US stocks mixed on Thurs. Dow Jones down 50 pts. Motorola Solutions Inc shares up 9.5% after reporting strong Q2 results & raised guidance.
seekingalpha.com Clover Health Investments, Corp. (CLOV) Q2 2026 Earnings Call Transcript Clover Health Investments, Corp. (CLOV) Q2 2026 Earnings Call Transcript
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 31.4% to $0.88 during Wednesday's after-market session. The company's market cap stands at $4.2 million. Caris Life Sciences…
benzinga.com Clover Health Investments Raises FY2026 Sales Guidance from $2.810B-$2.920B to $2.920B-$3.000B vs $2.910B Est Clover Health Investments (NASDAQ:CLOV) raises FY2026 sales outlook from $2.810 billion-$2.920 billion to $2.920 billion-$3.000 billion vs $2.910 billion estimate.- benzinga.com Clover Health Investments Q2 EPS $0.05 Beats $0.03 Estimate, Sales $743.167M Beat $728.267M Estimate Clover Health Investments (NASDAQ:CLOV) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03 by 66.67 percent. This is a 350 percent increase over losses…
- benzinga.com Canaccord Genuity Maintains Buy on Clover Health Investments, Raises Price Target to $5.5 Canaccord Genuity analyst Richard Close maintains Clover Health Investments (NASDAQ:CLOV) with a Buy and raises the price target from $4.2 to $5.5.
benzinga.com Insurer Elevance Seeks Recalculated Medicare Star Rating in Lawsuit Elevance sued HHS and CMS, alleging unequal Medicare Star Ratings treatment cost it about $115 million in 2027 bonus payments.
benzinga.com Cramer Gives Vistra His Blessing, Backs Stryker, Steers Clear Of AI-Exposed FICO Jim Cramer endorsed Vistra, expressed caution on Fair Isaac over AI risks: "I'm not going to get in the crosshairs anymore."
benzinga.com Clover Health Investments' Clover Care Services CEO Brady Priest Stepping Down; Co. Integrating Its Home-Care Business With Its Broader Operations; Not Appointing Priest's Successor https://www.sec.gov/ix?doc=/Archives/edgar/data/1801170/000180117026000153/clov-20260615.htm- benzinga.com UBS Maintains Neutral on Clover Health Investments, Raises Price Target to $4.75 UBS analyst Jonathan Yong maintains Clover Health Investments (NASDAQ:CLOV) with a Neutral and raises the price target from $2.75 to $4.75.
benzinga.com Clover Health Stock Extends Gains After Court Forces CMS to Upgrade Medicare Star Rating Clover Health shares are extending Wednesday's 18.9% surge after a court-ordered Medicare upgrade lifted its PPO plan to 4.5 Stars.- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com Caseys General Stores Upbeat Q4 Earnings, Joins Applied Optoelectronics, Clover Health Investments And Other Big Stocks Moving Higher On Wednesday US stocks down, Dow Jones fell 150 pts on Wed. Caseys General Stores Inc (CASY) shares up 14.4% after beating earnings. Other big gainers incl. CBRL, PLBL, RXT, YB, AXTI, AAOI, LMND, CLOV, TGTX,…- benzinga.com Clover Health Announces That Its 2026 Star Rating Has Been Recalculated At 4.5 Following U.S. Court's Summary Judgement On June 9, 2026, CMS informed Clover that, consistent with the Court's order, it has recalculated Clover's 2026 Star Rating as 4.5 Stars, and has instructed Clover to submit alternate bids at 4.5…
benzinga.com Canaccord Genuity Maintains Buy on Clover Health Investments, Raises Price Target to $4.2 Canaccord Genuity analyst Richard Close maintains Clover Health Investments (NASDAQ:CLOV) with a Buy and raises the price target from $3.2 to $4.2.
benzinga.com Jim Cramer Won't Recommend Mortgage Stocks Because 'I Never Know What They Really Own' — But He Loves Intel's 'Burgeoning Packaging Division' Cramer criticizes Clover Health's quarterly results, recommends Amkor for semiconductor packaging, and expresses caution over mortgage stocks.
benzinga.com Lowe's, ZTO Express, Viavi Solutions And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session US stock futures higher, Lowe's shares fall after reporting earnings. Other stocks declining in pre-market trading. Photo via Shutterstock
benzinga.com Earnings Scheduled For May 6, 2026 - benzinga.com Clover Health Investments Affirms FY2026 Sales Guidance of $2.810B-$2.920B vs $2.878B Est Clover Health Investments (NASDAQ:CLOV) affirms FY2026 sales outlook from $2.810 billion-$2.920 billion to $2.810 billion-$2.920 billion vs $2.878 billion estimate.
benzinga.com Clover Health Investments Q1 EPS $0.05 Beats $0.03 Estimate, Sales $749.200M Beat $714.893M Estimate Clover Health Investments (NASDAQ:CLOV) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03 by 66.67 percent. The company reported quarterly sales of…